ExodusPoint Capital Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-137,392
Closed -$3.16M 2019
2025
Q4
$3.16M Buy
137,392
+30,817
+29% +$1.01M 0.04% 621
2025
Q3
$3.21M Buy
+106,575
New +$3.2M 0.04% 564
2025
Q2
Sell
-7,991
Closed -$289K 1908
2025
Q1
$289K Sell
7,991
-79,026
-91% -$3.29M ﹤0.01% 1235
2024
Q4
$3.66M Buy
+87,017
New +$4.32M 0.04% 531
2024
Q2
Sell
-38,025
Closed -$1.77M 1920
2024
Q1
$1.77M Buy
+38,025
New +$1.79M 0.02% 754
2023
Q2
Sell
-70,864
Closed -$2.84M 2188
2023
Q1
$2.84M Buy
+70,864
New +$3.04M 0.03% 741
2022
Q4
Sell
-27,980
Closed -$1.16M 2046
2022
Q3
$1.16M Buy
+27,980
New +$1.44M 0.02% 1049
2021
Q3
Sell
-31,991
Closed -$3.05M 2540
2021
Q2
$3.05M Buy
+31,991
New +$3.33M 0.05% 510
2020
Q4
Sell
-2,965
Closed -$244K 2321
2020
Q3
$244K Buy
+2,965
New +$246K 0.01% 1387

Other funds holding RARE